Purpose The aim of the study was to evaluate serum uric acid (UA) levels before and after non-invasive positive pressure ventilation (NPPV) 
Introduction
Continuous nocturnal oxygen desaturation due to sleepassociated hypoventilation results in daytime hypoxemia and hypercapnia in patients with chronic respiratory failure (CRF) (1) . A possible sequela of sleep-associated hypoxemia is tissue hypoxia (2) . Hypoxic conditions trigger a purine degradation cascade (3) (4) (5) . Increased plasma levels and excretion of purine metabolites have also been observed in exercising human subjects (6) and in critically ill patients (7) under conditions of hypoxia and ischemia. Serum adenosine, a purine metabolite, may be a more sensitive marker of tissue hypoxia than uric acid (UA). However, the measurement of adenosine is technically difficult because of its short halflife in plasma (8) . Consequently, UA is widely used as a clinical marker of tissue hypoxia because it is not metabolized further, and it is easy to sample and inexpensive to as-sess (9) .
Serum and urinary UA are reported to be useful markers reflecting hypoxia in patients with various diseases such as obstructive sleep apnea syndrome (OSAS) (2, (8) (9) (10) (11) , chronic obstructive pulmonary disease (COPD) (9, 12, 13) , chronic heart failure (14, 15) , primary pulmonary hypertension (16) , cyanotic congenital heart disease (17) , and Eisenmenger syndrome (18) . The therapeutic effects of oxygen and nasal continuous positive airway pressure (nCPAP) on UA excretion in hypoxemic patients have been examined. Oxygen therapy markedly reduced excretion of urinary UA in COPD patients (12) . Additionally, several studies showed that overnight use of nCPAP reduced the urinary UA/creatinine ratio (UA/Cr) in OSAS patients (8) (9) (10) (11) .
Efficacy of long-term non-invasive positive pressure ventilation (NPPV) in patients with CRF has been reported (19) . In general, NPPV acts by relieving respiratory muscle fatigue, improving respiratory system compliance by reversing microatelectasis of the lung, and lowering the respiratory center "set point" for CO2 by ameliorating chronic hypoventilation (19 (19, 20 (22) . KS was defined as a Cobb angle of >50° ( 23) .
Patients and Methods

Study subjects
All patients met the selection guidelines for long-term non-invasive ventilation for RTD, as previously reported (19) . In brief, all patients showed typical symptoms such as morning headaches, daytime hypersomnolence, energy loss, and impaired gas exchange attributable to chronic daytime and sustained nocturnal hypoventilation (19 (8) (9) (10) (11) 25) .
Measurement of change in serum UA (∆UA/Cr)
∆UA/Cr was calculated as described previously (2) (27) .
Comparison of patients with and without a decrease in serum UA
Patients were classified into two groups according to T a b l e 1 . B a s e l i n e Ch a r a c t e r i s t i c s o f S t u d y P a t i e n t s ( n = 2 9 )
whether serum UA/Cr decreased after NPPV therapy: a UA/ Cr decrease group and a non-UA/Cr decrease group. 
Statistical analysis
0001). In addition, PaCO2 decreased significantly after NPPV therapy (P=0.0003).
There were no significant changes in serum creatinine, total protein, albumin, and hemoglobin levels after NPPV therapy.
As shown in Fig. 1 Fig. 3 T a b l e 2 . Ar t e r i a l B l o o d Ga s a n d L a b o r a t o r y Va l u e s b e f o r e a n d a f (8) (9) (10) (11) (12) . Basal urinary excretion of adenosine triphosphate catabolic products including UA has been shown to be significantly greater in severely hypoxemic COPD patients than in control patients and to be significantly decreased after oxygen therapy (12) . Moreover, in OSAS patients, a significant increase in the UA/Cr has been observed in association with nocturnal hypoxia; nCPAP treatment led to a significant reduction in this ratio (8) (9) (10) (11) (29) . Oxygen delivery to the periphery is determined by two major factors: oxygen content of arterial blood, which is calculated by the hemoglobin concentration, SaO2, and PaO2, and the amount of blood flow, i.e., cardiac output (29) . Other factors such as the oxyhemoglobin dissociation curve and pH also influence oxygen delivery. Thus, levels of PaO2 correlate poorly with tissue hypoxia (9) . In addition, improvement of pulmonary hypertension leads to a decrease in serum UA. Serum UA levels decreased in association with a reduction in total pul-F i g u r e 2 . Co r r e l a t i o n b e t we e n Δ UA a n d c h a n g e s i n b l o o d g a s v a l u e s . Δ UA = 1 0 0 % × ( s e r u m UA a f t e r NP P V t h e r a p y -s e r u m UA b e f o r e NP P V t h e r a p y ) / s e r u m UA b e f o r e NP P V t h e r a p y ; Δ O2 = P a O2 a f t e r NP P V t h e r a p y -P a O2 b e f o r e NP P V t h e r a p y ; Δ CO2 = P a CO2 a f t e r NP P V t h e r a p y -P a CO2 b e f o r e NP P V t h e r a p y . P v a l u e o b t a i n e d b y S p e a r ma n ' s r a n k c o r r e l a t i o n c o e f f i c i e n t . F i g u r e 3 . Ka p l a n -Me i e r p l o t s h o wi n g t h e p r o p o r t i o n o f p at i e n t s wi t h o u t e x a c e r b a t i o n o f CRF i n e a c h o f t h e t wo s t u d y  g r o u p s . T h e UA d e c r e a s e g r o u p h a d a s i g n i f i c a n t l y h i g h e r  p r o p o r t i o n o f p a t i e n t s wh o d i d n o t s u f f e r e x a c e r b a t i o n o f  CRF t h a n t h e n o n -UA d e c r e a s e g r o u p h a d ( P = 0 . 0 0 0 3 b y l o g  r a n k t e s t ) . CRF = c h r o n i c r e s p i r a t o r y f a i l u r e . monary resistance during vasodilator therapy in patients with primary pulmonary hypertension (16) . In patients with RTD, long-term NPPV therapy reportedly improved pulmonary hemodynamics (30, 31 (15, 16) and that it is a strong prognostic marker in patients with chronic heart failure (14, 15) , primary pulmonary hypertension (16) , and Eisenmenger syndrome (18 (2, 9) . In this study, 52% of patients (15 of 29) were taking loop diuretics, and 24% of patients (7 of 29) 
. The proportion was significantly higher in the UA/Cr decrease group than in the non-UA/Cr decrease group (P=0.0003).
F i g u r e 1 . S e r u m UA l e v e l s b e f o r e a n d a f t e r t r e a t me n t wi t h NP P V. S e r u m UA d i d n o t c h a n g e s i g n i f i c a n t l y a f t e r NP P V t h e r a p y ( P = 0 . 0 6 8 8 ) . UA = u r i c a c i d ; B e f o r e = b e f o r e NP P V t h e r a p y ; Af t e r = a f t e r NP P V t h e r a p y . P v a l u e o b t a i n e d b y Wi l c o x i n t e s t .
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